[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100517545":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":11,"locations":17,"responsibleParty":33,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":7,"eligibilityCriteria":43,"healthyVolunteers":44,"sex":45,"minAge":7,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Sichuan Cancer Hospital and Research Institute","OTHER",null,[9],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"No intervention",[12],{"name":13,"role":14,"phone":15,"phoneExt":7,"email":16},"Dengfeng Wang, Learned scholar","CONTACT","15982222707","wonderful_96@163.com",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":7,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Sichuan Cancer Hospital","RECRUITING","Chengdu","China","CN",{"type":25,"coordinates":26},"Point",[27,28],104.06667,30.66667,{"lat":28,"lon":27},[31],{"name":32,"role":14,"phone":15,"phoneExt":7,"email":16},"Wang Dengfeng, Doctor",{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Dengfeng Wang","Deputy chief","100517545","a-cohort-establishment-study-of-total-management-of-ovarian-cancer-100517545",false,"NCT06018935","A Cohort Establishment Study of Total Management of Ovarian Cancer","A Cohort Establishment Study of Total Management of Ovarian Cancer (Including Fallopian Tube Cancer and Primary Peritoneal Cancer)","Inclusion Criteria:\n\n1. Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital;\n2. Can cooperate with later follow-up.\n\nExclusion Criteria:\n\n1. Patients with other malignant tumors or previous history of other malignant tumors;\n2. Have cognitive impairment.",true,"FEMALE",{"count":47,"type":48},500,"ESTIMATED","OBSERVATIONAL","A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).",[52,53],"Tumor of Female Reproductive System","Ovarian Cancer",[55,56,57],"Ovarian cancer","Cohort study","Whole-process management","2024-06-17",{"date":60,"type":61},"2024-06-20","ACTUAL",{"date":58,"type":61},{"date":64,"type":48},"2025-09-01",{"name":5,"class":6},1]